These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37791922)

  • 1. Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent.
    Wilde B; Diamond JB; Laborda TJ; Frank L; O'Gorman MA; Kocolas I
    J Adolesc Health; 2024 Jan; 74(1):202-204. PubMed ID: 37791922
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-related hepatotoxicity and hepatic failure following combined androgen blockade.
    Castro Beza I; Sánchez Ruiz J; Peracaula Espino FJ; Villanego Beltrán MI
    Clin Transl Oncol; 2008 Sep; 10(9):591-2. PubMed ID: 18796378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents.
    Shumer D; Roberts SA
    J Adolesc Health; 2024 Jan; 74(1):5-6. PubMed ID: 38103922
    [No Abstract]   [Full Text] [Related]  

  • 4. Bicalutamide-associated fulminant hepatotoxicity.
    O'Bryant CL; Flaig TW; Utz KJ
    Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents.
    Neyman A; Fuqua JS; Eugster EA
    J Adolesc Health; 2019 Apr; 64(4):544-546. PubMed ID: 30612811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced photosensitivity to bicalutamide - case report and review of the literature.
    Lee K; Oda Y; Sakaguchi M; Yamamoto A; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 May; 32(3):161-4. PubMed ID: 26663090
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.
    Sasada K; Sakabe J; Tamura A; Kasuya A; Shimauchi T; Ito T; Hirakawa S; Tokura Y
    Eur J Dermatol; 2012; 22(3):402-3. PubMed ID: 22503957
    [No Abstract]   [Full Text] [Related]  

  • 9. Bicalutamide-induced gynaecomastia: do we have the answer?
    Di Lorenzo G; Autorino R
    Eur Urol; 2007 Jul; 52(1):5-8. PubMed ID: 17258386
    [No Abstract]   [Full Text] [Related]  

  • 10. Bicalutamide-associated hallucinations in a metastatic prostate cancer patient: A case report.
    Turkkan G; Dogan C; Tek B
    J Oncol Pharm Pract; 2020 Jun; 26(4):1029-1031. PubMed ID: 31707924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vismodegib-associated hepatotoxicity: a potential side effect detected in postmarketing surveillance.
    Ventarola DJ; Silverstein DI
    J Am Acad Dermatol; 2014 Aug; 71(2):397-8. PubMed ID: 25037792
    [No Abstract]   [Full Text] [Related]  

  • 12. Bicalutamide causes heart failure in an elderly patient with prostate cancer.
    Guirguis K
    Expert Opin Drug Saf; 2016; 15(3):297-302. PubMed ID: 26745594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients.
    Ismail FF; Meah N; Trindade de Carvalho L; Bhoyrul B; Wall D; Sinclair R
    J Am Acad Dermatol; 2020 Nov; 83(5):1478-1479. PubMed ID: 32213304
    [No Abstract]   [Full Text] [Related]  

  • 14. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
    Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F
    Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DRUG-INDUCED INTERSTITIAL LUNG DISEASE DURING COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LEUPRORELIN ACETATE FOR PROSTATE CANCER].
    Maeda K; Osafune T; Masuda Y; Takeda T; Kageyama S; Narita M; Kawauchi A
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):36-40. PubMed ID: 31956217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of gynecomastia induced by bicalutamide].
    Haddad E
    Ann Urol (Paris); 2006 Dec; 40 Suppl 2():S49-52. PubMed ID: 17361921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.
    Ho TH; Nunez-Nateras R; Hou YX; Bryce AH; Northfelt DW; Dueck AC; Wong B; Stanton ML; Joseph RW; Castle EP
    Clin Genitourin Cancer; 2017 Apr; 15(2):196-202.e1. PubMed ID: 27771244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
    Serretta V; Altieri V; Morgia G; Nicolosi F; De Grande G; Mazza R; Melloni D; Allegro R; Ferraù F; Gebbia V
    Clin Genitourin Cancer; 2012 Sep; 10(3):174-9. PubMed ID: 22502790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bicalutamide-induced breast events.
    Sieber PR
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1773-9. PubMed ID: 18062751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity Associated With Vismodegib: Could Dose Reduction Be an Effective Management?
    de Perosanz-Lobo D; Burgos-Blasco P; Moreno-Arrones OM; Bea-Ardebol S
    Dermatol Surg; 2021 Jul; 47(7):1006-1007. PubMed ID: 34167133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.